HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation

Hongmei Ye, Xinyu Wang, Siyu Meng, Xuchen Song, Xu He, Lin Huang, Xiaohong Zhang, Jing Guo

Open source

DOI
10.1161/jaha.125.046773
Published
2026-07-07
Container
Journal of the American Heart Association
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/jaha.125.046773,
  title = {HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation},
  author = {Hongmei Ye and Xinyu Wang and Siyu Meng and Xuchen Song and Xu He and Lin Huang and Xiaohong Zhang and Jing Guo},
  year = {2026},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.125.046773},
  url = {https://doi.org/10.1161/jaha.125.046773}
}

RIS

TY  - JOUR
TI  - HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation
AU  - Hongmei Ye
AU  - Xinyu Wang
AU  - Siyu Meng
AU  - Xuchen Song
AU  - Xu He
AU  - Lin Huang
AU  - Xiaohong Zhang
AU  - Jing Guo
PY  - 2026
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.125.046773
UR  - https://doi.org/10.1161/jaha.125.046773
ER  - 

APA

Ye, H., Wang, X., Meng, S., Song, X., He, X., Huang, L., Zhang, X., & Guo, J. (2026). HNRNPC as a Novel Therapeutic Target for Ischemic Heart Disease: Evidence From Mendelian Randomization and Experimental Validation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.046773

Source records